Bis(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum
C96H73F3N13Pt3-9 — CID 160682651
Data last refreshed: (MolForge compound catalog, from PubChem)
About Bis(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum
Bis(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum (PubChem CID 160682651) has the molecular formula C96H73F3N13Pt3-9 and a molecular weight of 2050.96 g/mol. Its IUPAC name is bis(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum.
Molecular Properties
| Compound Name | Bis(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum |
|---|---|
| PubChem CID | 160682651 |
| Molecular Formula | C96H73F3N13Pt3-9 |
| Molecular Weight | 2050.96 g/mol |
| Exact Mass | 2049.51 |
| IUPAC Name | bis(2,4-dimethyl-5-phenylimidazol-1-ide);3,5-dimethyl-1-phenyl-4-(4-phenylphenyl)pyrazole;bis(1-phenyl-4-(4-phenylphenyl)pyrazole);3-phenyl-5-(trifluoromethyl)-1,4-diaza-2-azanidacyclopenta-3,5-diene;platinum |
| SMILES | Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nc(C)c(-c2[c-]cccc2)[n-]1.Cc1nn(-c2[c-]cccc2)c(C)c1-c1ccc(-c2ccccc2)cc1.FC(F)(F)c1n[n-]c(-c2[c-]cccc2)n1.[Pt].[Pt].[Pt].[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1.[c-]1ccccc1-n1cc(-c2ccc(-c3ccccc3)cc2)cn1 |
| InChI | InChI=1S/C23H19N2.2C21H15N2.2C11H10N2.C9H4F3N3.3Pt/c1-17-23(18(2)25(24-17)22-11-7-4-8-12-22)21-15-13-20(14-16-21)19-9-5-3-6-10-19;2*1-3-7-17(8-4-1)18-11-13-19(14-12-18)20-15-22-23(16-20)21-9-5-2-6-10-21;2*1-8-11(13-9(2)12-8)10-6-4-3-5-7-10;10-9(11,12)8-13-7(14-15-8)6-4-2-1-3-5-6;;;/h3-11,13-16H,1-2H3;2*1-9,11-16H;2*3-6H,1-2H3;1-4H;;;/q3*-1;3*-2;;; |
| InChIKey | ZRKRKMAAEOIIFQ-UHFFFAOYSA-N |
| XLogP | 21.79 |
| TPSA | 147.32 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 10 |
| Rotatable Bonds | 12 |
| Heavy Atoms | 115 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2050.96 |
| LogP ≤ 5 | 21.79 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 10 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Carbo_cation/anion', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 160682651 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.